MP Biomedicals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MP Biomedicals's estimated annual revenue is currently $120.4M per year.(i)
  • MP Biomedicals's estimated revenue per employee is $155,000

Employee Data

  • MP Biomedicals has 777 Employees.(i)
  • MP Biomedicals grew their employee count by 1% last year.

MP Biomedicals's People

NameTitleEmail/Phone
1
CMO (Fractional)Reveal Email/Phone
2
VP Fine ChemicalsReveal Email/Phone
3
Global Director Information TechnologyReveal Email/Phone
4
Director, Global AccountsReveal Email/Phone
5
Director SalesReveal Email/Phone
6
Director OperationsReveal Email/Phone
7
Global ERP Project DirectorReveal Email/Phone
8
Global Fine Chemicals Technical DirectorReveal Email/Phone
9
Director, Quality and RegulatoryReveal Email/Phone
10
Global Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is MP Biomedicals?

About MP Biomedicals Overview MP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality. Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic vision to expand from California into Russia and China, placing ICN in a position to take advantage of the emerging world economy in the new millennium.

keywords:N/A

N/A

Total Funding

777

Number of Employees

$120.4M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MP Biomedicals News

2022-04-20 - Tropical Spastic Paraparesis Diagnosis Market 2022 Development ...

MP Biomedicals, Fujirebio, Inc., Quest Diagnostics, DiaSorin S.p.A., Merck. Tropical Spastic Paraparesis Diagnosis Market Overview:.

2022-04-20 - Global Podophyllin Market 2022 Key Companies Growth by 2028 ...

Global Podophyllin Market 2022 Key Companies Growth by 2028 – MP Biomedicals, Perrigo, Himpharm, Haoxiang.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M7826%N/A
#2
$198.8M7929%N/A
#3
$327M8657%N/A
#4
$266.4M9000%$20M
#5
$318.4M90625%N/A